Screener
Eligibility screening
A Study Comparing Pembrolizumab and Sacituzumab Govitecan to Standard of Care for Urothelial Cancer
114 US sites in CA, FL, GA, IA +18
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.